C57BL/6JCya-Tbc1d31em1/Cya
Common Name:
Tbc1d31-KO
Product ID:
S-KO-17948
Background:
C57BL/6JCya
Product Type
Age
Genotype
Sex
Quantity
Price:
Contact for Pricing
Basic Information
Strain Name
Tbc1d31-KO
Strain ID
KOCMP-210544-Tbc1d31-B6J-VB
Gene Name
Product ID
S-KO-17948
Gene Alias
4B3; D330013L20Rik; Gm85; Wdr67
Background
C57BL/6JCya
NCBI ID
Modification
Conventional knockout
Chromosome
15
Phenotype
Document
Application
--
Note: When using this mouse strain in a publication, please cite “C57BL/6JCya-Tbc1d31em1/Cya mice (Catalog S-KO-17948) were purchased from Cyagen.”
Strain Description
Ensembl Number
ENSMUST00000022992
NCBI RefSeq
NM_001081396
Target Region
Exon 3~8
Size of Effective Region
~22.8 kb
Detailed Document
Overview of Gene Research
Tbc1d31, a Rab GTPase activating protein, is involved in multiple biological processes. It assembles a complex at centrosomes with E3 ubiquitin ligase praja2, protein kinase A (PKA), and OFD1, playing a crucial role in primary ciliogenesis. This process links GPCR signalling to ubiquitylation and proteolysis of OFD1, which is important for cilium biology and development [1].
In hepatocellular carcinoma (HCC), genomic amplification of Tbc1d31 promotes tumour growth and metastasis. It reduces the Rab22A-mediated endolysosomal trafficking and degradation of EGFR, activating EGFR signalling. Additionally, ZSCAN16 can activate TBC1D31 transcriptionally, accelerating HCC progression [2,3]. A homozygous missense variant in Tbc1d31 has been associated with congenital anomalies of the kidney and urinary tract (CAKUT) in humans [4]. In breast cancer, Tbc1d31 is among TBC1 domain-containing proteins expressed at higher levels in triple-negative breast cancers, correlating with elevated glycolytic metabolism [5].
In conclusion, Tbc1d31 is essential for primary ciliogenesis and is involved in multiple disease conditions such as HCC, CAKUT, and triple-negative breast cancer. Studies on Tbc1d31 contribute to understanding biological processes and disease mechanisms, potentially offering new therapeutic strategies for these diseases.
References:
1. Senatore, Emanuela, Chiuso, Francesco, Rinaldi, Laura, Conte, Ivan, Feliciello, Antonio. 2021. The TBC1D31/praja2 complex controls primary ciliogenesis through PKA-directed OFD1 ubiquitylation. In The EMBO journal, 40, e106503. doi:10.15252/embj.2020106503. https://pubmed.ncbi.nlm.nih.gov/33934390/
2. Cao, Pengbo, Chen, Hongxia, Zhang, Ying, He, Fuchu, Zhou, Gangqiao. 2024. Genomic Amplification of TBC1D31 Promotes Hepatocellular Carcinoma Through Reducing the Rab22A-Mediated Endolysosomal Trafficking and Degradation of EGFR. In Advanced science (Weinheim, Baden-Wurttemberg, Germany), 11, e2405459. doi:10.1002/advs.202405459. https://pubmed.ncbi.nlm.nih.gov/39206796/
3. Wang, Xiaofang, Xiao, Bo, Zhong, Fuping, Wang, Qibo, Jiang, Jihao. 2024. ZSCAN16 expedites hepatocellular carcinoma progression via activating TBC1D31. In Cell division, 19, 31. doi:10.1186/s13008-024-00135-9. https://pubmed.ncbi.nlm.nih.gov/39511655/
4. Saygılı, Seha, Koşukcu, Can, Baştuğ, Turgut, Çalışkan, Salim, Ozaltin, Fatih. 2023. A novel homozygous missense variant in TBC1D31 in a consanguineous family with congenital anomalies of the kidney and urinary tract (CAKUT). In Clinical genetics, 104, 679-685. doi:10.1111/cge.14406. https://pubmed.ncbi.nlm.nih.gov/37468454/
5. Lupi, Mariadomenica, Avanzato, Daniele, Confalonieri, Stefano, Di Fiore, Pier Paolo, Lanzetti, Letizia. 2024. TBC1 domain-containing proteins are frequently involved in triple-negative breast cancers in connection with the induction of a glycolytic phenotype. In Cell death & disease, 15, 647. doi:10.1038/s41419-024-07037-2. https://pubmed.ncbi.nlm.nih.gov/39231952/
Quality Control Standard
Sperm Test
Pre-cryopreservation: Measurement of sperm concentration, determination of sperm viability.
Post-cryopreservation: A vial of cryopreserved sperms is selected for in-vitro fertilization from each batch.
Environmental Standards:SPF
Available Region:Global
Source:Cyagen